Cargando…

Repurposing Immunomodulatory Drugs to Combat Tuberculosis

Tuberculosis (TB) is an infectious disease caused by an obligate intracellular pathogen, Mycobacterium tuberculosis (M.tb) and is responsible for the maximum number of deaths due to a single infectious agent. Current therapy for TB, Directly Observed Treatment Short-course (DOTS) comprises multiple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fatima, Samreen, Bhaskar, Ashima, Dwivedi, Ved Prakash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076598/ https://www.ncbi.nlm.nih.gov/pubmed/33927718 http://dx.doi.org/10.3389/fimmu.2021.645485

Ejemplares similares

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
por: Verma, Akanksha, et al.
Publicado: (2022)

Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals
por: Fatima, Samreen, et al.
Publicado: (2021)

Editorial: Repurposed Drugs as Immune-Modulators to Combat Infectious Diseases
por: Mishra, Bibhuti B., et al.
Publicado: (2022)

Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2
por: Negi, Kriti, et al.
Publicado: (2023)

Host sirtuin 2 as an immunotherapeutic target against tuberculosis
por: Bhaskar, Ashima, et al.
Publicado: (2020)

Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases
por: Devi, Annu, et al.
Publicado: (2023)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis
por: Pahuja, Isha, et al.
Publicado: (2023)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
por: Lee, Chiyun, et al.
Publicado: (2021)

Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020)

Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020)

Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis
por: Kumar, Santosh, et al.
Publicado: (2021)

Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis*
por: Rahman, Md. Aejazur, et al.
Publicado: (2015)

Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis
por: Pahuja, Isha, et al.
Publicado: (2023)

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs
por: Schor, Stanford, et al.
Publicado: (2018)

Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)

Mycobacterium tuberculosis Directs T Helper 2 Cell Differentiation by Inducing Interleukin-1β Production in Dendritic Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

Repurposing mucosal delivery devices for live attenuated tuberculosis vaccines
por: Puri, Munish, et al.
Publicado: (2023)

Withaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses
por: Kumari, Anjna, et al.
Publicado: (2023)

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity
por: Rao Muvva, Jagadeeswara, et al.
Publicado: (2021)

Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2015)

Combating COVID-19: The role of drug repurposing and medicinal plants
por: Khan, Shah A., et al.
Publicado: (2021)

Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
por: Thangamani, Shankar, et al.
Publicado: (2015)

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
por: Pires, David, et al.
Publicado: (2021)

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
por: Martinez, Miguel Angel
Publicado: (2021)

Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
por: Jung, Yoo Jin, et al.
Publicado: (2021)

Preparing for the next pandemic: Simulation-based deep reinforcement learning to discover and test multimodal control of systemic inflammation using repurposed immunomodulatory agents
por: Cockrell, Chase, et al.
Publicado: (2022)

Clinical features and mechanistic insights into drug repurposing for combating COVID-19
por: Asrani, Purva, et al.
Publicado: (2022)

Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs
por: D'Souza, Criselle, et al.
Publicado: (2021)

Immunomodulatory Drugs in the Management of SARS-CoV-2
por: Burrage, Daniel R., et al.
Publicado: (2020)

Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022)

Editorial: Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
por: Maghazachi, Azzam A.
Publicado: (2017)

Immunomodulatory properties of morphine and the hypothesised role of long-term opioid use in the immunopathogenesis of tuberculosis
por: Bataduwaarachchi, Vipula R., et al.
Publicado: (2023)

Drug-Repurposing Approach To Combat Staphylococcus aureus: Biomolecular and Binding Interaction Study
por: Singh, Vishakha, et al.
Publicado: (2022)

Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021)

Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
por: Kersten, Kelly, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ovmdlkshsrjb0p5f4cegsq3qkv